Smith Kevin Raymond Merrill - Net Worth and Insider Trading
Smith Kevin Raymond Merrill Net Worth
The estimated net worth of Smith Kevin Raymond Merrill is at least $446,943 dollars as of 2025-06-03. Smith Kevin Raymond Merrill is the CEO and President of Inogen Inc and owns about 70,274 shares of Inogen Inc (INGN) stock worth over $446,943. Details can be seen in Smith Kevin Raymond Merrill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Smith Kevin Raymond Merrill has not made any transactions after 2025-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Smith Kevin Raymond Merrill
Smith Kevin Raymond Merrill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Smith Kevin Raymond Merrill owns 1 companies in total, including OncoSec Medical Inc (ONCSQ) .
Click here to see the complete history of Smith Kevin Raymond Merrill’s form 4 insider trades.
Insider Ownership Summary of Smith Kevin Raymond Merrill
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCSQ | OncoSec Medical Inc | 2020-02-07 | director |
Smith Kevin Raymond Merrill Latest Holdings Summary
Smith Kevin Raymond Merrill currently owns a total of 1 stock. Smith Kevin Raymond Merrill owns 70,274 shares of Inogen Inc (INGN) as of March 3, 2025, with a value of $446,943.
Latest Holdings of Smith Kevin Raymond Merrill
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INGN | Inogen Inc | 2025-03-03 | 70,274 | 6.36 | 446,943 |
Holding Weightings of Smith Kevin Raymond Merrill
Smith Kevin Raymond Merrill Form 4 Trading Tracker
According to the SEC Form 4 filings, Smith Kevin Raymond Merrill has made a total of 1 transactions in Inogen Inc (INGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inogen Inc is the acquisition of 11,709 shares on March 3, 2025, which cost Smith Kevin Raymond Merrill around $100,229.
Insider Trading History of Smith Kevin Raymond Merrill
- 1
Smith Kevin Raymond Merrill Trading Performance
GuruFocus tracks the stock performance after each of Smith Kevin Raymond Merrill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Smith Kevin Raymond Merrill is -20.97%. GuruFocus also compares Smith Kevin Raymond Merrill's trading performance to market benchmark return within the same time period. The performance of stocks bought by Smith Kevin Raymond Merrill within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Smith Kevin Raymond Merrill's insider trading performs compared to the benchmark.
Performance of Smith Kevin Raymond Merrill
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.28 |  | | | | |
| Relative Return to S&P 500(%) | -5.53 | | | | | |
Smith Kevin Raymond Merrill Ownership Network
Ownership Network List of Smith Kevin Raymond Merrill
Ownership Network Relation of Smith Kevin Raymond Merrill
Smith Kevin Raymond Merrill Owned Company Details
What does OncoSec Medical Inc do?
Who are the key executives at OncoSec Medical Inc?
Smith Kevin Raymond Merrill is the director of OncoSec Medical Inc. Other key executives at OncoSec Medical Inc include Principal Accounting Officer Robert J Delaversano , President and CEO Robert H. Arch , and Chief Financial Officer George Chi .
OncoSec Medical Inc (ONCSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of OncoSec Medical Inc (ONCSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoSec Medical Inc (ONCSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
OncoSec Medical Inc (ONCSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoSec Medical Inc Insider Transactions
Smith Kevin Raymond Merrill Mailing Address
Above is the net worth, insider trading, and ownership report for Smith Kevin Raymond Merrill. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Smith Kevin Raymond Merrill's mailing address is: Marblehead Ma 01945.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
